ARCHIVES

NCI Peer Review: Consumer Advocates Named To Panels Reviewing Center Grants, ECOG Renewal

This article is from The Cancer Letter archive.

Vol. 24 No. 33 | September 4, 1998

Download PDF Visit The Full Archive

Related Articles

Three Institutes To Test BioMicro’s Microarray Product. GlycoDesign Allowed Patent For Cancer Drug GD0039.

March 1, 2002

PRI’s Frederick Fee $903,866 For First Six Months Of New Contract

September 2, 1988

AACR, ASCO Publish Reports Examining U.S. Cancer Care

April 4, 2014

Durant Suggests Six Efforts Needed For Survival Of Clinical Research

May 30, 1986

Cancer Program Depend On Vitality Of Centers, Broder ells DCPC Board

May 12, 1989

In Brief: SBA Writing Guidelines to Implement Act Giving 1.25 Percent Of R&D Budget To Small Business

July 23, 1982